Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/15/2014 04/16/2014 04/17/2014 04/21/2014 04/22/2014 Date
24.79(c) 26.46(c) 25.97(c) 27.39(c) 28.72(c) Last
1 383 232 1 202 115 865 796 1 366 725 1 812 882 Volume
+0.65% +6.74% -1.85% +5.47% +4.86% Change
More quotes
Company
Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company. It focuses on developing and marketing products to predominantly specialist audiences, such as urologists, endocrinologists, certain targeted primary care physicians, hand surgeons, subsets of orthopedic, general, and plastic... 
Surperformance© rating of Auxilium Pharmaceuticals,
Trading Rating : Investor Rating :
More about the company
Chart AUXILIUM PHARMACEUTICALS,
Duration : Period :
Auxilium Pharmaceuticals,  Technical Analysis Chart | AUXL | US05334D1072 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 484 M
EBIT 2014 69,5 M
Net income 2014 -27,3 M
Debt 2014 411 M
Yield 2014 -
Sales 2015 565 M
EBIT 2015 124 M
Net income 2015 37,9 M
Debt 2015 287 M
Yield 2015 -
PER 2014 -
PER 2015 48,21
EV / Sales 2014 3,83x
EV / Sales 2015 3,06x
Capitalization 1 443 M
More Financials
Latest news on AUXILIUM PHARMACEUTICALS,
7d ago SWEDISH ORPHAN BIOVITRUM : Sobi Becomes Market Authorisation Holder For Xiapex i..
04/14 AUXILIUM PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Ex..
04/14 AUXILIUM PHARMACEUTICALS : and Sobi Announce Encore Presentation of XIAFLEX/Xiap..
04/07 AUXILIUM PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Ex..
04/07 AUXILIUM PHARMACEUTICALS : Sobi Becomes Market Authorisation Holder For Xiapex i..
04/07 SWEDISH ORPHAN BIOVITRUM : Sobi becomes market authorisation holder for Xiapex i..
03/27 AUXILIUM PHARMACEUTICALS : National Law Firm Announces Testim Testosterone Lawsu..
03/17 AUXILIUM PHARMACEUTICALS : To Announce Fourth Quarter And Full Year 2013 Results..
03/17 AUXILIUM PHARMACEUTICALS : To Present At The Barclay's Global Healthcare Confere..
03/17 AUXILIUM PHARMACEUTICALS : To Present At The Cowen And Company Annual Healthcare..
03/17 AUXILIUM PHARMACEUTICALS : Announces Fourth Quarter And Full Year 2013 Financial..
03/17 AUXILIUM PHARMACEUTICALS : To Present At The RBC Capital Markets Healthcare Conf..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
Auxilium Pharmaceuticals,  : Income Statement Evolution
More Financials
EPS Revisions
Auxilium Pharmaceuticals,  : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF